Patrick Marcellin

71.3k citations
730 papers · 58.5k · 21 hit papers · h-index 117

Impact in

  • Hepatology top 0.01%
    • Hepatitis C virus research
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver Disease and Transplantation
    • Liver physiology and pathology
  • Epidemiology top 0.01%
    • Hepatitis B Virus Studies
    • Liver Disease Diagnosis and Treatment

Papers in

    • Hepatitis C virus research 394
    • Liver Disease and Transplantation 15
    • Hepatocellular Carcinoma Treatment and Prognosis 11
    • Liver physiology and pathology 8
    • Liver Diseases and Immunity 7
    • Hepatitis B Virus Studies 292
    • Liver Disease Diagnosis and Treatment 38

Patrick Marcellin

715 papers receiving 55.8k citations

Patrick Marcellin's Hit Papers

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study 2019 · 500 citations
5000+7+14Years since publication5001k1.5k

Peers

Patrick Marcellin
Comparison fields: 5 of 167
  • Hepatology 30.4k
  • Epidemiology 25.9k
  • Pharmacology 642
  • Radiology, Nuclear Medicine and Imaging 1.1k
  • Infectious Diseases 892
Replace Anna Suk-Fong Lok with:
Anna Suk-Fong Lok United States
Zachary D Goodman United States
Eugene R. Schiff United States
Thomas Berg Germany
Thierry Poynard France
Adrian M. Di Bisceglie United States
Edward John Gane New Zealand
Stefan Zeuzem Germany
Antonio Craxı̀ Italy
Heiner H. Wedemeyer Germany
Patrick Marcellin relative to Anna Suk-Fong Lok United States Anna Suk-Fong Lok's profile →
Citations per field
00.5×1.5×
Anna Suk-Fong Lok · 1×
Citations per year

Countries citing papers authored by Patrick Marcellin

Since Specialization
Citations

This map shows the geographic impact of Patrick Marcellin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Marcellin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Marcellin more than expected).

Fields of papers citing papers by Patrick Marcellin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Marcellin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Marcellin. The network helps show where Patrick Marcellin may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick Marcellin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Marcellin Line = papers co-authored together Patrick Marcellin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 730 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
Hit paper breakdown →
20042373
2
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
Hit paper breakdown →
19981989
3
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Hit paper breakdown →
20111981
4
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Hit paper breakdown →
20121488
5
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Hit paper breakdown →
20141454
6
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Hit paper breakdown →
20111341
7
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C
Hit paper breakdown →
20041256
8
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
Hit paper breakdown →
20051252
9
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B
Hit paper breakdown →
20031097
10
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
Hit paper breakdown →
2016996
11
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Hit paper breakdown →
2008970
12
Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B
Hit paper breakdown →
2004921
13
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B
Hit paper breakdown →
2003811
14
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆
Hit paper breakdown →
2004788
15
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
Hit paper breakdown →
2006759
16
Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes
Hit paper breakdown →
2010728
17
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Hit paper breakdown →
2019500
18 1997482
19 2006481
20 2007455

About Patrick Marcellin

Patrick Marcellin is a scholar working on Hepatology, Epidemiology, Pharmacology, Endocrinology, Diabetes and Metabolism and Immunology, having authored 730 papers that have together received 58.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (394 papers), Hepatitis B Virus Studies (292 papers), Liver Disease Diagnosis and Treatment (38 papers), Liver Disease and Transplantation (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver physiology and pathology (8 papers), Liver Diseases and Immunity (7 papers) and Organ Transplantation Techniques and Outcomes (4 papers). The work is most often cited by research in Hepatology (30.4k citations), Epidemiology (25.9k citations), Pharmacology (642 citations), Radiology, Nuclear Medicine and Imaging (1.1k citations) and Infectious Diseases (892 citations). Patrick Marcellin has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Tarik Asselah, Nathalie Boyer, Michelle Martinot-Peignoux, Stephanos J. Hadziyannis, Victor de Lédinghen, Dominique Charles Valla, Michel Beaugrand, Claude Degott, Zachary D Goodman and Marianne Ziol. Their work appears in journals such as Journal of Hepatology, Hepatology, Liver International, Gastroenterology and Journal of Viral Hepatitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact